Immunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trial

Guckenberger, M.Opitz, I.Dafni, U.Fontecedro, A. CurioniScherz, A.Elicin, O.Addeo, A.Aerts, J. G. J. V.Dingemans, A-M.Hendriks, L.Jimenez Munarriz, B.Juan-Vidal, O.Sullivan, I.Valdivia, J.Piguet, A-C.Roschitzki-Voser, H.Ehrbar, S.Baumgartl, M.Peters, S.Stahel, R. A.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/26249enImmunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trialconference outputopen access10.1016/j.annonc.2020.08.17311569-8041http://www.annalsofoncology.org/article/S0923753420417272/pdf573469102010